Author： Arseneau Kristen O Cominelli Fabio
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.22, Iss.7, 2013-11, pp. : 907-913
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Adalimumab a charming treatment for Crohn's disease
Inpharma, Vol. 1, Iss. 1544, 2006-01 ,pp. :
Access to resources
Recommend
Evolving Treatment Algorithms in Crohn's Disease
Current Drug Targets, Vol. 19, Iss. 7, 2018-04 ,pp. :
Crohn's Disease: A Review of Current Treatment with a Focus on Biologics
By Panés Julián
Drugs, Vol. 67, Iss. 17, 2007-01 ,pp. :
Certolizumab pegol a PRECiSE treatment for Crohn's disease
Inpharma, Vol. 1, Iss. 1547, 2006-01 ,pp. :
Natalizumab shows potential in the treatment of Crohn's disease
Inpharma, Vol. 1, Iss. 1542, 2006-01 ,pp. :